Andrew R. Rezvani

Palo Alto Institute — United States

Medicine · Health Sciences

34h-index5.3kcitations203works4.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hematopoietic Stem Cell Transplantation(97), CAR-T cell therapy research(44), Acute Lymphoblastic Leukemia research(32), Lymphoma Diagnosis and Treatment(29), Acute Myeloid Leukemia Research(29)

Publications203 total

Exploring facilitators and barriers to daily chlorhexidine gluconate bathing in adult patients undergoing hematopoietic stem cell transplantation
UNC Libraries·2025Open Access
Post-transplant cyclophosphamide vs tacrolimus/methotrexate: Improved GRFS, reduced NRM, and less severe GVHD in myeloablative HLA-matched allogeneic transplantation
Blood·2025Open Access
CD22-directed CAR-T cells induce complete remissions in high-risk follicular and Mantle Cell Lymphoma with limited neurotoxicity
Blood·2025Open Access
Secondary graft failure after PT-cy: Modeling a candidate risk assignment biomarker based on lymphocyte reconstitution.  Results from the BMT CTN 1801 study.
Blood·2025Open Access
Allogeneic HSC and regulatory T cell  (Orca-T) engineered cell therapy following reduced intensity conditioning: Results of a single center Phase 1 study
Blood·2025
Double-dose axicabtagene ciloleucel (Axi-Cel-2) as second-line therapy for high-risk relapsed or refractory large B-cell lymphoma (r/rLBCL): Interim results from a Phase 1b study
Blood·2025Open Access
Combined TCR-seq and single-cell RNA-seq reveal distinct origins for antiviral immunity after post-transplant cyclophosphamide and tac/MTX gvhd prophylaxis: Results from the BMT CTN 1801 study
Blood·2025
Patients with TP53-mutated AML/MDS without complex or monosomal karyotype can achieve durable survival benefits with allogeneic HCT
Blood·2025Open Access
Superior efficacy and persistence of Orca-T-allogeneic CAR19/22 versus autologous CAR19/22 in high-risk adult B-ALL
Blood·2025Open Access
Evaluating thymic stromal lymphopoietin (TSLP) as a biomarker in acute graft versus host disease
Blood·2025Open Access
CAR19 therapy drives expansion of clonal hematopoiesis and associated cytopenias
2025Open Access
Exploring Perspectives on Feasibility, Challenges, and Support Needs for Chlorhexidine Gluconate (CHG) Bathing in the Outpatient Setting for Hematopoietic Cell Transplant Recipients: A Qualitative Study
Transplantation and Cellular Therapy·2025
The Impact of Anti-CD38 Monoclonal Antibody Therapy on Stem-Cell Mobilization Yields in Patients With Newly Diagnosed Multiple Myeloma (NDMM) Referred From Community and Academic Oncology Practices: Single Center, Real World Data 2021-2024
Transplantation and Cellular Therapy·2025· 2 cited
Impact of posttransplant cyclophosphamide-based GVHD prophylaxis in patients 70 years and older: an update from BMT CTN 1703
Blood Advances·2025· 4 citedOpen Access
Accurate prediction of absolute prokaryotic abundance from DNA concentration
Cell Reports Methods·2025· 2 citedOpen Access
Omidubicel-onlv Transplantation for Hematologic Malignancies: Results of a Multicenter Expanded Access Program
Transplantation and Cellular Therapy·2025· 1 citedOpen Access
Graft-versus-host disease prophylaxis shapes T cell biology and immune reconstitution after hematopoietic cell transplant
2025· 5 citedOpen Access
Comparison of Post-Transplant Cyclophosphamide Vs Methotrexate and Calcineurin Inhibitor for Gvhd Prophylaxis in Myeloablative Transplants with HLA Matched Donors
Transplantation and Cellular Therapy·2025· 1 cited
Determinants of Post-CAR Myeloid Neoplasms Evolving after Lymphoma Therapy
Transplantation and Cellular Therapy·2025
CD22-Directed CAR T-Cell Therapy Achieves Complete Remission in CD19-Directed CAR T-Cell Refractory Follicular and Mantle Cell Lymphoma with Superior Safety and Absence of Neurotoxicity
Transplantation and Cellular Therapy·2025· 1 cited
page 1 of 11Next →

Frequent Co-authors

David B. Miklos(20), Robert S. Negrin(19), Lori Muffly(18), Sally Arai(18), Robert Lowsky(17), Everett Meyer(16), Judith A. Shizuru(15), Matthew J. Frank(14), Wen‐Kai Weng(14), Parveen Shiraz(13), Laura Johnston(13), Surbhi Sidana(12), Bita Sahaf(10), John Tamaresis(10), Mehdi Hamadani(9), Rainer Storb(8), Brenda M. Sandmaier(7), Jay Y. Spiegel(6), Hillard M. Lazarus(6), Mohamed A. Kharfan‐Dabaja(6)